DRKS00015439已完成不适用
Assessment of safety and glycaemia during application of the hybrid closed-loop system on the basis of the AndroidAPS application. - ASCENT
Diabetes Poland0 个研究点目标入组 12 人开始时间: 2018年9月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 40 Years（—）
- 性别
- All
入选标准
- •1. age 18-40
- •2. type 1 diabetes
- •3. duration of diabetes > 5 years
- •4. treatment with a personal insulin pump from > 1 year
- •5. using the bolus calculator
- •6. experience in CGM system: using o f= 70% of the time in the last 3 months
- •7. HbA1c <9%
- •8. BMI 18-30 kg / m2
- •9. consent to participate in the study
排除标准
- •1. persistence of partial remission of type 1 diabetes
- •2. identified advanced chronic micro- and macroangiopathic complications of diabetes (proliferative retinopathy, diabetic kidney disease with eGFR <60 mL/min/1.73 m2, cardiac autonomic neuropathy, coronary heart disease, stroke)
- •3. severe hypoglycemia in the last year
- •4. hypoglycemia unawareness
- •5. ketoacidosis in the last 3 months
- •6. accompanying diseases except hypothyroidism in the state of euthyreosis
- •7. eating disorders, depression
- •8. smoking
研究者
相似试验
招募中
2 期
Investigation of whether metformin can be used safely and effectively in patients with type 2 diabetes on haemodialysisType 2 DiabetesACTRN12612000352808Dr Tilenka Thynne6
尚未招募
2 期
Investigation of whether metformin can be used safely and effectively in patients with type 2 diabetes on peritoneal dialysisChronic kidney Disease- on peritoneal dialysisMetabolic and Endocrine - DiabetesRenal and Urogenital - Kidney diseaseType 2 DiabetesACTRN12612000864820Tilenka Thynne6
Unknown
不适用
Comparative Study of GlySure Continuous Intra-vascular Glucose Monitoring and Intermittent Monitoring in Medical ICUBlood Glucose Monitoring in Medical ICUNCT02142088GlySure60
Unknown
不适用
Effects on Glycemic Control of WBF-0031 in Subjects With Abnormal Glucose ToleranceAbnormal Glucose ToleranceNCT04490460Eden Miller30
撤回
不适用
GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life PracticeDiabetes Mellitus, Type 2NCT01915264Bayer